Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Regulatory Affairs
Return to: PBR Home | Regulatory Affairs | Suppliers

The Use of Continuous ECG Recordings (Holters) in Drug Development; Copyright, December 2014

Published 17 February 2015 | By ERT

Continuous 12 lead ECG recorders, often referred to as Holter devices, offer specific advantages to be considered over the standard 12 lead ECGs often collected during clinical trials for cardiac safety. This white paper explores the history of Holters, how sponsors, sites, and patients use these devices, and the benefits of continuous ECG recordings.

Available Downloads

The Use of Continuous ECG Recordings (Holters) in Drug Development; Copyright, December 2014